Insightra Medical India Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 6.06 Cr
as on 17-07-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.25 M
as on 17-07-2024
- Satisfied Charges ₹ 6.36 M
as on 17-07-2024
- Revenue 28.74%
(FY 2023)
- Profit 413.29%
(FY 2023)
- Ebitda 65.87%
(FY 2023)
- Net Worth 133.68%
(FY 2023)
- Total Assets -30.69%
(FY 2023)
About Insightra Medical India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.06 Cr.
The company currently has active open charges totaling ₹5.25 M. The company has closed loans amounting to ₹6.36 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Malik and Simha Varakavi serve as directors at the Company.
- CIN/LLPIN
U33112GA2011FTC006796
- Company No.
006796
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
21 Sep 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Mapusa Bardez, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Insightra Medical India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Malik  | Director | 07-Oct-2019 | Current |
| Simha Varakavi | Director | 07-Oct-2019 | Current |
Financial Performance of Insightra Medical India.
Insightra Medical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.74% increase. The company also saw a substantial improvement in profitability, with a 413.29% increase in profit. The company's net worth Soared by an impressive increase of 133.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Insightra Medical India?
In 2023, Insightra Medical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Op. Bank Ltd. Creation Date: 23 Oct 2013 | ₹5.25 M | Open |
Others Creation Date: 30 Jan 2017 | ₹3.94 M | Satisfied |
The Saraswat Co-Operative Bank Ltd Creation Date: 29 Mar 2012 | ₹2.42 M | Satisfied |
How Many Employees Work at Insightra Medical India?
Insightra Medical India has a workforce of 4 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Insightra Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Insightra Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
